Insider · CIK 0001577899
Raymond J. Furey
Files at RIGL (RIGEL PHARMACEUTICALS INC). First filing Feb 6, 2025, latest Feb 6, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RIGL: RIGEL PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | RIGLsell RIGEL PHARMACEUTICALS INC | $60k 2,787 shares | -7% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -877 | $47.50 | $42k | 50,559 | 39 d ago |
| Sep 15, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +7,394 | $0.00 | $0 | 7,394 | Sep 17, 2025 |
| Mar 17, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +9,375 | $0.00 | $0 | 9,375 | Mar 19, 2025 |
| Mar 17, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +7,850 | $0.00 | $0 | 7,850 | Mar 19, 2025 |
| Feb 4, 2025 | RIGL RIGEL PHARMACEUTICALS INC | SOpen-market sale Common Stock | -1,448 | $20.92 | $30k | 40,169 | Feb 6, 2025 |
| Feb 5, 2025 | RIGL RIGEL PHARMACEUTICALS INC | SOpen-market sale Common Stock | -1,339 | $21.93 | $29k | 38,830 | Feb 6, 2025 |
| Jan 29, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Common Stock | +19,717 | $0.00 | $0 | 41,617 | Jan 31, 2025 |
| Jan 29, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (Right to Buy)derivative | +14,788 | $0.00 | $0 | 14,788 | Jan 31, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.